Pfizer Inc (XBRU:PFEBC)
€ 21.65 0 (0%) Market Cap: 136.41 Bil Enterprise Value: 188.78 Bil PE Ratio: 0 PB Ratio: 1.76 GF Score: 75/100

Pfizer Inc at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 07:40PM GMT
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

So thanks, everyone, for joining us for the Pfizer session. I just need to refer you to disclaimers at www.morganstanley.com/researchdisclosures. It's my pleasure to welcome Frank D'Amelio. He is Executive Vice President of Business Operations and Chief Financial Officer, and he's been with the company now 12 years, so time flies. But I thought it would be great to have you, Frank, start with a few opening remarks, and then we'll take it from there.

Frank A. D;Amelio
Pfizer Inc. - CFO & EVP of Global Supply & Business Operations

' -

Just I think this is, what, the third or fourth year in a row you and I have done this conference?

David Reed Risinger;Frank A. D<
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

Yes.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot